Header Logo

KEVIN W. GAREY

TitleProfessor. Chair, Department of Pharmacy Practice and Translational Research.
InstitutionUniversity of Houston
DepartmentPharmacy Practice and Translational Research
AddressHealth 2 4849 Calhoun Road, Room 4039
Houston, TX 77204-5039
Houston TX 77204-5039
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R03AI178015     (GONZALES-LUNA, ANNE J)Feb 1, 2024 - Dec 31, 2025
    NIH
    Vancomycin Susceptibility Measures to Evaluate C. difficile infection Outcomes
    Role: Co-Principal Investigator
    R01AI139261     (HURDLE, JULIAN G)Aug 20, 2018 - Jan 31, 2028
    NIH
    Decoding the clinical impact of the recent evolution of metronidazole resistance on Clostridium difficile infection.
    Role: Co-Principal Investigator
    R44AI136176     (YANG, ZHIYONG)Jan 20, 2018 - Jul 31, 2025
    NIH
    A Serological Assay for Neutralizing Antitoxin Response in Patients with Clostridioides difficile Infection (Phase II)
    Role: Co-Principal Investigator
    U01AI124290     (SAVIDGE, TOR)Aug 20, 2016 - Jul 31, 2021
    NIH
    Decoding Antibiotic-induced Susceptibility to Clostridium difficile Infection
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wolfe TM, Jo J, Pinkham NV, Garey KW, Walk ST. Microbiome impact of ibezapolstat and other Clostridioides difficile infection relevant antibiotics using humanized mice. bioRxiv. 2024 Nov 07. PMID: 39574673; PMCID: PMC11580883.
      Citations:    
    2. Le TM, Eubank TA, McKelvey AM, Cao X, Hurdle JG, Garey KW. Fidaxomicin resistance in Clostridioides difficile: a systematic review and predictive modeling with RNA polymerase binding sites. Antimicrob Agents Chemother. 2024 Nov 06; e0120624. PMID: 39503488.
      Citations:    Fields:    
    3. Kuijper EJ, Garey KW, Kuijper EJ, Garey KW. The New Horizon of Clostridioides difficile Infection Treatment. Gastroenterology. 2024 Nov 05. PMID: 39505220.
      Citations:    Fields:    
    4. Rao K, Garey KW. From Chaos to Clarity? The Quest for Effective Probiotics in Antibiotic-Associated Diarrhea. Open Forum Infect Dis. 2024 Nov; 11(11):ofae616. PMID: 39529940; PMCID: PMC11551611.
      Citations:    
    5. Eubank TA, Dureja C, Gonzales-Luna AJ, Hurdle JG, Garey KW. Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Specific Ribotypes. Open Forum Infect Dis. 2024 Nov; 11(11):ofae588. PMID: 39512425; PMCID: PMC11542623.
      Citations:    
    6. Midani FS, Danhof HA, Mathew N, Ardis CK, Garey KW, Spinler JK, Britton RA. Emerging Clostridioides difficile ribotypes have divergent metabolic phenotypes. bioRxiv. 2024 Aug 15. PMID: 39185189; PMCID: PMC11343193.
      Citations:    
    7. Eubank TA, Dureja C, Garey KW, Hurdle JG, Gonzales-Luna AJ, Eubank TA, Dureja C, Garey KW, Hurdle JG, Gonzales-Luna AJ. Reduced Vancomycin Susceptibility in Clostridioides difficile Is Associated With Lower Rates of Initial Cure and Sustained Clinical Response. Clin Infect Dis. 2024 Jul 19; 79(1):15-21. PMID: 38382090; PMCID: PMC11259216.
      Citations: 2     Fields:    Translation:HumansCells
    8. Okhuysen PC, Ramesh MS, Louie T, Kiknadze N, Torre-Cisneros J, de Oliveira CM, Van Steenkiste C, Stychneuskaya A, Garey KW, Garcia-Diaz J, Li J, Duperchy E, Chang BY, Sukbuntherng J, Montoya JG, Styles L, Clow F, James D, Dubberke ER, Wilcox M. A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response. Clin Infect Dis. 2024 Jun 14; 78(6):1462-1472. PMID: 38305378; PMCID: PMC11175683.
      Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
    9. Eubank TA, Jantarathaneewat K, Jo J, Garey KW. Estimating Clostridioides difficile infection-associated readmission rates: A systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2024 May 27; 1-5. PMID: 38800851.
      Citations:    Fields:    
    10. Hu C, Wang W, Jo J, Garey KW. Erratum to "Development and validation of LC-MS/MS for quantifying omadacycline from stool for gut microbiome studies" [J. Chromatogr. B 1236 (2024) 124057]. J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Jul 01; 1241:124166. PMID: 38795458.
      Citations:    Fields:    
    11. Hu C, Wang W, Jo J, Garey KW. Development and validation of LC-MS/MS for quantifying omadacycline from stool for gut microbiome studies. J Chromatogr B Analyt Technol Biomed Life Sci. 2024 Apr 01; 1236:124057. PMID: 38447241.
      Citations: 1     Fields:    Translation:Humans
    12. Bass?res E, Eubank TA, Begum K, Alam MJ, Jo J, Le TM, Lancaster CK, Gonzales-Luna AJ, Garey KW. Antibacterial activity of ibezapolstat against antimicrobial-resistant clinical strains of Clostridioides difficile. Antimicrob Agents Chemother. 2024 Mar 06; 68(3):e0162123. PMID: 38364016; PMCID: PMC10916401.
      Citations:    Fields:    Translation:HumansCells
    13. Hu C, Garey KW. Microscopy methods for Clostridioides difficile. Anaerobe. 2024 Apr; 86:102822. PMID: 38341023.
      Citations:    Fields:    Translation:HumansCells
    14. Feuerstadt P, Allegretti JR, Dubberke ER, Guo A, Harvey A, Yang M, Garcia-Horton V, Fillbrunn M, Tillotson G, Bancke LL, LaPlante K, Garey KW, Khanna S. Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile Infection. Infect Dis Ther. 2024 Jan; 13(1):221-236. PMID: 38236515; PMCID: PMC10828144.
      Citations: 1     
    15. Jo J, Hu C, Begum K, Wang W, Le TM, Agyapong S, Hanson BM, Ayele H, Lancaster C, Jahangir Alam M, Gonzales-Luna AJ, Garey KW. Fecal Pharmacokinetics and Gut Microbiome Effects of Oral Omadacycline Versus Vancomycin in Healthy Volunteers. J Infect Dis. 2024 01 12; 229(1):273-281. PMID: 38051631; PMCID: PMC10786255.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    16. Lodise TP, Garey KW, Aram JA, Nathanson BH. Healthcare Resource Utilization and Discharge Readiness in Adult Hospitalized Patients With Candidemia or Invasive Candidiasis Who Received an Echinocandin: An Analysis of United States Hospitals. Open Forum Infect Dis. 2024 Jan; 11(1):ofad703. PMID: 38213636; PMCID: PMC10783265.
      Citations:    
    17. Murphy BR, Dailey Garnes NJ, Hwang H, Peterson CB, Garey KW, Okhuysen P. Increased Prevalence of Clostridioides difficile Infection Among Pediatric Oncology Patients: Risk Factors for Infection and Complications. Pediatr Infect Dis J. 2024 Feb 01; 43(2):136-141. PMID: 38134390; PMCID: PMC11102345.
      Citations:    Fields:    Translation:HumansCells
    18. Gonzales-Luna AJ, Carlson TJ, Garey KW. Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence. Clin Infect Dis. 2023 12 05; 77(Suppl 6):S487-S496. PMID: 38051970.
      Citations: 1     Fields:    Translation:HumansCells
    19. Snydman DR, McDermott LA, Thorpe CM, Goldstein EJC, Schuetz AN, Johnson S, Gerding DN, Gluck L, Bourdas D, Carroll KC, Lancaster CK, Garey KW, Wang Q, Walk ST, Duperchy E. A US-based national surveillance study for the susceptibility and epidemiology of Clostridioides difficile isolates with special reference to ridinilazole: 2020-2021. Antimicrob Agents Chemother. 2023 10 18; 67(10):e0034923. PMID: 37728368; PMCID: PMC10583687.
      Citations:    Fields:    Translation:HumansCells
    20. Wu Q, Boonma P, Badu S, Yalcinkaya N, So SY, Garey KW, Williams K, Arnold LE, Shulman RJ, Kellermayer R, Savidge TC. Donor-recipient specificity and age-dependency in fecal microbiota therapy and probiotic resolution of gastrointestinal symptoms. NPJ Biofilms Microbiomes. 2023 08 03; 9(1):54. PMID: 37537181; PMCID: PMC10400536.
      Citations:    Fields:    Translation:HumansCells
    21. Garey KW, Dubberke ER, Guo A, Harvey A, Yang M, Garc?a-Horton V, Fillbrunn M, Wang H, Tillotson GS, Bancke LL, Feuerstadt P. Effect of Fecal Microbiota, Live-Jslm (REBYOTA [RBL]) on Health-Related Quality of Life in Patients With Recurrent Clostridioides difficile Infection: Results From the PUNCH CD3 Clinical Trial. Open Forum Infect Dis. 2023 Aug; 10(8):ofad383. PMID: 37564743; PMCID: PMC10411038.
      Citations: 4     
    22. Zasowski EJ, Ali M, Anugo A, Ibragimova N, Dotson KM, Endres BT, Begum K, Alam MJ, Garey KW. Comparison of Risk Stratification Approaches to Identify Patients with Clostridioides difficile Infection at Risk for Multidrug-Resistant Organism Gut Microbiota Colonization. Infect Dis Ther. 2023 Aug; 12(8):2005-2015. PMID: 37436677; PMCID: PMC10505131.
      Citations:    
    23. Olaitan AO, Dureja C, Youngblom MA, Topf MA, Shen WJ, Gonzales-Luna AJ, Deshpande A, Hevener KE, Freeman J, Wilcox MH, Palmer KL, Garey KW, Pepperell CS, Hurdle JG. Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile. Nat Commun. 2023 07 12; 14(1):4130. PMID: 37438331; PMCID: PMC10338468.
      Citations: 7     Fields:    Translation:CellsPHPublic Health
    24. Gonzales-Luna AJ, Dureja C, Eubank TA, Garey KW, Hurdle JG. Surveillance of Clostridioides difficile Antimicrobial Resistance in the United States. Clin Infect Dis. 2023 06 08; 76(11):2038-2039. PMID: 36883582; PMCID: PMC10249984.
      Citations:    Fields:    Translation:HumansCells
    25. Zaki A, Gonzales-Luna AJ, Beyda ND, Lasco T, Garey KW. Micafungin pharmacodynamics predict clinical outcomes in hospitalized patients with candidemia caused by certain Candida species. Pharmacotherapy. 2023 06; 43(6):466-472. PMID: 37067155.
      Citations:    Fields:    Translation:HumansAnimals
    26. Mason CS, Avis T, Hu C, Nagalingam N, Mudaliar M, Coward C, Begum K, Gajewski K, Alam MJ, Bass?res E, Moss S, Reich S, Duperchy E, Fox KR, Garey KW, Powell DJ. The Novel DNA Binding Mechanism of Ridinilazole, a Precision Clostridiodes difficile Antibiotic. Antimicrob Agents Chemother. 2023 05 17; 67(5):e0156322. PMID: 37093023; PMCID: PMC10246881.
      Citations:    Fields:    Translation:HumansCells
    27. Banz A, Miller M, Villafuerte-G?lvez JA, Pollock NR, Alonso CD, Chen X, Xu H, Wang L, White N, Daugherty K, Gonzalez-Luna AJ, Barrett C, Sprague R, Garey KW, Kelly CP. Reply to Ito. Clin Infect Dis. 2023 04 17; 76(8):1529-1530. PMID: 36533701; PMCID: PMC10319973.
      Citations:    Fields:    
    28. Gonzales-Luna AJ, Skinner AM, Alonso CD, Bouza E, Cornely OA, de Meij TGJ, Drew RJ, Garey KW, Gerding DN, Johnson S, Kahn SA, Kato H, Kelly CP, Kelly CR, Kociolek LK, Kuijper EJ, Louie T, Riley TV, Sandora TJ, Vehreschild MJGT, Wilcox MH, Dubberke ER, EXPAND Cdiff group. Redefining Clostridioides difficile infection antibiotic response and clinical outcomes. Lancet Infect Dis. 2023 07; 23(7):e259-e265. PMID: 37062301.
      Citations:    Fields:    Translation:HumansCells
    29. Garey KW, Feuerstadt P, Dubberke ER, Guo A, Tillotson GS. Effect of fecal microbial transplantation on Clostridioides difficile infection: dysbiosis, metabolites and health related quality of life. Open Forum Infect Dis. 2023 Mar; 10(3):ofad113. PMID: 36968968; PMCID: PMC10036674.
      Citations:    
    30. Banegas M, Villafuerte-G?lvez J, Paredes R, Sprague R, Barrett C, Gonzales-Luna AJ, Daugherty K, Garey KW, Xu H, Lin Q, Wang L, Chen X, Pollock NR, Kelly CP, Alonso CD. Preservation of the Innate Immune Response to Clostridioides difficile Infection in Hospitalized Immunocompromised Patients. Open Forum Infect Dis. 2023 Mar; 10(3):ofad090. PMID: 36949876; PMCID: PMC10026545.
      Citations:    
    31. Lapin B, Garey KW, Wu H, Pham SV, Huang SP, Reese PR, Wang E, Deshpande A. Validation of a Health-Related Quality of Life Questionnaire in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Phase 3 Randomized Trial. Clin Infect Dis. 2023 02 08; 76(3):e1195-e1201. PMID: 35789381.
      Citations:    Fields:    
    32. Villafuerte G?lvez JA, Pollock NR, Alonso CD, Chen X, Xu H, Wang L, White N, Banz A, Miller M, Daugherty K, Gonzalez-Luna AJ, Barrett C, Sprague R, Garey KW, Kelly CP. Stool Interleukin-1? Differentiates Clostridioides difficile Infection (CDI) From Asymptomatic Carriage and Non-CDI Diarrhea. Clin Infect Dis. 2023 02 08; 76(3):e1467-e1475. PMID: 35906836; PMCID: PMC10169396.
      Citations:    Fields:    
    33. Gonzales-Luna AJ, Carlson TJ, Garey KW. Emerging Options for the Prevention and Management of Clostridioides difficile Infection. Drugs. 2023 Feb; 83(2):105-116. PMID: 36645620; PMCID: PMC9841950.
      Citations:    Fields:    Translation:Humans
    34. Sandora TJ, Kociolek LK, Williams DN, Daugherty K, Geer C, Cuddemi C, Chen X, Xu H, Savage TJ, Banz A, Garey KW, Gonzales-Luna AJ, Kelly CP, Pollock NR. Baseline stool toxin concentration is associated with risk of recurrence in children with Clostridioides difficile infection. Infect Control Hosp Epidemiol. 2023 09; 44(9):1403-1409. PMID: 36624698; PMCID: PMC10330943.
      Citations:    Fields:    Translation:HumansCells
    35. Hu C, Garey KW. Nonmammalian models to study Clostridioides difficile infection; a systematic review. Anaerobe. 2023 Feb; 79:102694. PMID: 36626950; PMCID: PMC9975065.
      Citations:    Fields:    Translation:AnimalsCells
    36. Garey KW, Jo J, Gonzales-Luna AJ, Lapin B, Deshpande A, Wang E, Hasson B, Pham SV, Huang SP, Reese PR, Wu H, Hohmann E, Feuerstadt P, Oneto C, Berenson CS, Lee C, McGovern B, vonMoltke L. Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2023 01 03; 6(1):e2253570. PMID: 36716031; PMCID: PMC9887497.
      Citations: 3     Fields:    Translation:Humans
    37. Tran TT, Cabrera NL, Gonzales-Luna AJ, Carlson TJ, Alnezary F, Miller WR, Sakurai A, Dinh AQ, Rydell K, Rios R, Diaz L, Hanson BM, Munita JM, Pedroza C, Shelburne SA, Aitken SL, Garey KW, Dillon R, Puzniak L, Arias CA. Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA. JAC Antimicrob Resist. 2023 Feb; 5(1):dlac131. PMID: 36601551; PMCID: PMC9806660.
      Citations:    
    38. Gonzales-Luna AJ, Carlson TJ, Garey KW. Gut microbiota changes associated with Clostridioides difficile infection and its various treatment strategies. Gut Microbes. 2023 Jan-Dec; 15(1):2223345. PMID: 37318134; PMCID: PMC10274544.
      Citations: 4     Fields:    Translation:Humans
    39. Endres BT, Basseres E, Citron DM, Tyrrell KL, Begum K, Lancaster C, Warren YA, Alam MJ, Garey KW, Goldstein EJC. Fusobacteria behaving badly: Masquerading strains of strictly anaerobic Escherichiacoli misidentified due to the deletion of the hemB gene. Anaerobe. 2023 Feb; 79:102682. PMID: 36580991.
      Citations:    Fields:    Translation:HumansCells
    40. Hu C, Wang W, Garey KW. Heterogeneity and lyophilization comparison of stool processing for gastrointestinal bile acid measurement by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2023 Jan 01; 1214:123569. PMID: 36527807; PMCID: PMC9839599.
      Citations:    Fields:    
    41. Alonso CD, Pollock NR, Garey KW, Gonzales-Luna AJ, Williams DN, Daugherty K, Cuddemi C, White NC, Chen X, Xu H, Sprague R, Barrett C, Villafuerte-G?lvez J, Miller M, Foussadier A, Lantz A, Banz A, Kelly CP. Higher In Vivo Fecal Concentrations of Clostridioides difficile Toxins A and B in Patients With North American Pulsed-Field Gel Electrophoresis Type 1/Ribotype 027 Strain Infection. Clin Infect Dis. 2022 11 30; 75(11):2019-2022. PMID: 35607815; PMCID: PMC10200326.
      Citations:    Fields:    
    42. Francisco DMA, Zhang L, Jiang Y, Olvera A, Adachi J, Guevara EY, Aitken SL, Garey KW, Peterson CB, Do KA, Dillon R, Obi EN, Jenq R, Okhuysen PC. Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer. Infect Dis Ther. 2023 Jan; 12(1):209-225. PMID: 36443547; PMCID: PMC9868205.
      Citations:    
    43. Sandora TJ, Williams DN, Daugherty K, Geer C, Cuddemi C, Kociolek LK, Chen X, Xu H, Savage TJ, Banz A, Garey KW, Gonzales-Luna AJ, Pollock NR, Kelly CP. Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age. J Pediatric Infect Dis Soc. 2022 Oct 25; 11(10):454-458. PMID: 35801632; PMCID: PMC9595052.
      Citations:    Fields:    
    44. Garey KW, McPherson J, Dinh AQ, Hu C, Jo J, Wang W, Lancaster CK, Gonzales-Luna AJ, Loveall C, Begum K, Jahangir Alam M, Silverman MH, Hanson BM. Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial. Clin Infect Dis. 2022 09 30; 75(7):1164-1170. PMID: 35134880; PMCID: PMC9525077.
      Citations:    Fields:    
    45. Jo J, Tran TT, Beyda ND, Simmons D, Hendrickson JA, Almutairi MS, Alnezary FS, Gonzales-Luna AJ, Septimus EJ, Garey KW. Development of the invasive candidiasis discharge [I Can discharge] model: a mixed methods analysis. Eur J Clin Microbiol Infect Dis. 2022 Oct; 41(10):1207-1213. PMID: 36002777; PMCID: PMC9489576.
      Citations:    
    46. Schroeder CP, Hengel RL, Nathan RV, Ritter TE, Obi EN, Lancaster C, Van Anglen LJ, Garey KW. Appropriate cleaning reduces potential risk of spore transmission from patients with Clostridioides difficile infection treated in outpatient infusion centers. Anaerobe. 2022 Oct; 77:102617. PMID: 35940371.
      Citations:    
    47. Alonso CD, Garey KW, Gonzales-Luna AJ, Williams D, Daugherty K, Cuddemi C, White NC, Chen X, Xu H, Sprague R, Barrett C, Pollock NR, Kelly CP, Villafuerte-G?lvez J, Miller M, Foussadier A, Lantz A, Banz A. Ultrasensitive and Quantitative Toxin Measurement Correlates With Baseline Severity, Severe Outcomes, and Recurrence Among Hospitalized Patients With Clostridioides difficile Infection. Clin Infect Dis. 2022 07 06; 74(12):2142-2149. PMID: 34537841; PMCID: PMC9258941.
      Citations:    Fields:    Translation:HumansCells
    48. McPherson J, Hu C, Begum K, Wang W, Lancaster C, Gonzales-Luna AJ, Loveall C, Silverman MH, Alam MJ, Garey KW. Functional and Metagenomic Evaluation of Ibezapolstat for Early Evaluation of Anti-Recurrence Effects in Clostridioides difficile Infection. Antimicrob Agents Chemother. 2022 08 16; 66(8):e0224421. PMID: 35862742; PMCID: PMC9380534.
      Citations:    Fields:    
    49. Garey KW, Rose W, Gunter K, Serio AW, Wilcox MH. Omadacycline and Clostridioides difficile: A Systematic Review of Preclinical and Clinical Evidence. Ann Pharmacother. 2023 02; 57(2):184-192. PMID: 35656828; PMCID: PMC9874691.
      Citations: 1     Fields:    
    50. Hengel RL, Schroeder CP, Jo J, Ritter TE, Nathan RV, Gonzales-Luna AJ, Obi EN, Dillon RJ, Van Anglen LJ, Garey KW. Recurrent Clostridioides difficile infection worsens anxiety-related patient-reported quality of life. J Patient Rep Outcomes. 2022 May 14; 6(1):49. PMID: 35567724; PMCID: PMC9107550.
      Citations:    
    51. Hu C, Beyda ND, Garey KW. A Vancomycin HPLC Assay for Use in Gut Microbiome Research. Microbiol Spectr. 2022 06 29; 10(3):e0168821. PMID: 35536037; PMCID: PMC9241942.
      Citations:    Fields:    Translation:Humans
    52. Jo J, Gonzales-Luna AJ, Lancaster CK, McPherson JK, Begum K, Jahangir Alam M, Garey KW. Multi-country surveillance of Clostridioides difficile demonstrates high prevalence of spores in non-healthcare environmental settings. Anaerobe. 2022 Jun; 75:102543. PMID: 35227896; PMCID: PMC9197859.
      Citations:    Fields:    Translation:HumansCells
    53. Eubank TA, Gonzales-Luna AJ, Hurdle JG, Garey KW. Genetic Mechanisms of Vancomycin Resistance in Clostridioides difficile: A Systematic Review. Antibiotics (Basel). 2022 Feb 16; 11(2). PMID: 35203860; PMCID: PMC8868222.
      Citations: 1     
    54. Carlson TJ, Gonzales-Luna AJ, Garey KW. Fulminant Clostridioides difficile Infection: A Review of Treatment Options for a Life-Threatening Infection. Semin Respir Crit Care Med. 2022 02; 43(1):28-38. PMID: 35172356.
      Citations:    Fields:    Translation:HumansCells
    55. Penna B, Endres BT, Garey KW, Rainha K, Lins D, Ferreira RF, Costa CL, Domingues RMCP, Ferreira EO. Colitis caused by Clostridioides difficile infection in a domestic dog: A case report. Anaerobe. 2022 Feb; 73:102511. PMID: 34990816.
      Citations:    Fields:    Translation:AnimalsCells
    56. Gonzales-Luna AJ, Carlson TJ, Garey KW. Antibiotic Therapies for Clostridioides difficile Infection in Children. J Pediatric Infect Dis Soc. 2021 Nov 17; 10(Supplement_3):S52-S57. PMID: 34791393.
      Citations:    Fields:    Translation:HumansCells
    57. Han Z, Lapin B, Garey KW, Donskey CJ, Deshpande A. Impact of Clostridioides difficile infection on patient-reported quality of life. Infect Control Hosp Epidemiol. 2022 10; 43(10):1339-1344. PMID: 34615561.
      Citations: 1     Fields:    
    58. Johnson S, Skinner AM, Gonzales-Luna AJ, Garey KW, Kelly CP, Wilcox MH, Lavergne V. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. Clin Infect Dis. 2021 09 07; 73(5):e1029-e1044. PMID: 34164674.
      Citations: 16     Fields:    Translation:HumansCells
    59. Johnson S, Skinner AM, Gonzales-Luna AJ, Garey KW, Kelly CP, Wilcox MH, Lavergne V. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. Clin Infect Dis. 2021 09 07; 73(5):755-757. PMID: 34492699.
      Citations: 9     Fields:    Translation:HumansCells
    60. Almutairi MS, Gonzales-Luna AJ, Alnezary FS, Fallatah SB, Alam MJ, Begum K, Garey KW. Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains. Anaerobe. 2021 Dec; 72:102440. PMID: 34461273; PMCID: PMC8678208.
      Citations:    Fields:    Translation:HumansCells
    61. Wu X, Shen WJ, Deshpande A, Olaitan AO, Palmer KL, Garey KW, Hurdle JG. The Integrity of Heme Is Essential for Reproducible Detection of Metronidazole-Resistant Clostridioides difficile by Agar Dilution Susceptibility Tests. J Clin Microbiol. 2021 08 18; 59(9):e0058521. PMID: 34132582; PMCID: PMC8373004.
      Citations: 4     Fields:    Translation:HumansCells
    62. Carlson TJ, Gonzales-Luna AJ, Wilcox MF, Theriault SG, Alnezary FS, Patel P, Ahn BK, Zasowski EJ, Garey KW. Corticosteroids Do Not Increase the Likelihood of Primary Clostridioides difficile Infection in the Setting of Broad-Spectrum Antibiotic Use. Open Forum Infect Dis. 2021 Oct; 8(10):ofab419. PMID: 34646906; PMCID: PMC8501294.
      Citations:    
    63. Alosaimy S, Lagnf AM, Morrisette T, Scipione MR, Zhao JJ, Jorgensen SCJ, Mynatt R, Carlson TJ, Jo J, Garey KW, Allen D, DeRonde K, Vega AD, Abbo LM, Venugopalan V, Athans V, Saw S, Claeys KC, Miller M, Molina KC, Veve M, Kufel WD, Amaya L, Yost C, Ortwine J, Davis SL, Rybak MJ. Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa. Open Forum Infect Dis. 2021 Aug; 8(8):ofab371. PMID: 34430671; PMCID: PMC8378588.
      Citations: 6     
    64. Gonzales-Luna AJ, Olaitan AO, Shen WJ, Deshpande A, Carlson TJ, Dotson KM, Lancaster C, Begum K, Alam MJ, Hurdle JG, Garey KW. Reduced Susceptibility to Metronidazole Is Associated With Initial Clinical Failure in Clostridioides difficile Infection. Open Forum Infect Dis. 2021 Aug; 8(8):ofab365. PMID: 34381844; PMCID: PMC8351808.
      Citations: 3     
    65. Deyhim N, Bhakta SB, Varkey AC, Metzen DL, Varkey D, Garey KW, Martinez RJ. Systemization of a pharmacy technician career ladder in a multi-hospital system. Explor Res Clin Soc Pharm. 2021 Jun; 2:100036. PMID: 35481131; PMCID: PMC9031433.
      Citations:    
    66. Miles-Jay A, Young VB, Pamer EG, Savidge TC, Kamboj M, Garey KW, Snitkin ES. A multisite genomic epidemiology study of Clostridioides difficile infections in the USA supports differential roles of healthcare versus community spread for two common strains. Microb Genom. 2021 06; 7(6). PMID: 34180789; PMCID: PMC8461479.
      Citations:    Fields:    Translation:HumansCells
    67. Alonso CD, Papamichael K, Sprague R, Barrett C, Gonzales-Luna AJ, Daugherty K, Garey KW, Xu H, Lin Q, Wang L, Chen X, Pollock NR, Villafuerte-G?lvez J, Kelly CP. Humoral Immune Response to Clostridioides difficile Toxins A and B in Hospitalized Immunocompromised Patients With C difficile Infection. Open Forum Infect Dis. 2021 Jul; 8(7):ofab286. PMID: 34258317; PMCID: PMC8271131.
      Citations:    
    68. Gonzales-Luna AJ, Spinler JK, Oezguen N, Khan MAW, Danhof HA, Endres BT, Alam MJ, Begum K, Lancaster C, Costa GP, Savidge TC, Hurdle JG, Britton R, Garey KW. Systems biology evaluation of refractory Clostridioides difficile infection including multiple failures of fecal microbiota transplantation. Anaerobe. 2021 Aug; 70:102387. PMID: 34044101; PMCID: PMC8384661.
      Citations: 3     Fields:    Translation:HumansCells
    69. Engevik MA, Danhof HA, Hall A, Engevik KA, Horvath TD, Haidacher SJ, Hoch KM, Endres BT, Bajaj M, Garey KW, Britton RA, Spinler JK, Haag AM, Versalovic J. The metabolic profile of Bifidobacterium dentium reflects its status as a human gut commensal. BMC Microbiol. 2021 05 24; 21(1):154. PMID: 34030655; PMCID: PMC8145834.
      Citations: 5     Fields:    Translation:HumansCells
    70. Yepez Guevara EA, Aitken SL, Olvera AV, Carlin L, Fernandes KE, Bhatti MM, Garey KW, Adachi J, Okhuysen PC. Clostridioides difficile Infection in Cancer and Immunocompromised Patients: Relevance of a Two-step Diagnostic Algorithm and Infecting Ribotypes on Clinical Outcomes. Clin Infect Dis. 2021 05 18; 72(10):e460-e465. PMID: 32803229.
      Citations: 2     Fields:    Translation:HumansCells
    71. Endres BT, Rashid T, Lancaster C, Begum K, Alam MJ, Garey KW, Bass?res E, Montes-Bravo N, P?rez-Soto N, Paredes-Sabja D. Visualization of fidaxomicin association with the exosporium layer of Clostridioides difficile spores. Anaerobe. 2021 Jun; 69:102352. PMID: 33640461.
      Citations:    Fields:    Translation:Cells
    72. Ke S, Pollock NR, Wang XW, Chen X, Daugherty K, Lin Q, Xu H, Garey KW, Gonzales-Luna AJ, Liu YY, Kelly CP. Integrating gut microbiome and host immune markers to understand the pathogenesis of Clostridioides difficile infection. Gut Microbes. 2021 Jan-Dec; 13(1):1-18. PMID: 34132169; PMCID: PMC8210874.
      Citations: 7     Fields:    Translation:HumansCells
    73. Carlson TJ, Gonzales-Luna AJ, Garey KW. Recent developments in antimicrobial therapy for gastrointestinal infections. Curr Opin Gastroenterol. 2021 01; 37(1):30-36. PMID: 33229860.
      Citations:    Fields:    Translation:HumansCells
    74. Crutchley RD, Jacobs DM, Gathe J, Mayberry C, Bulayeva N, Rosenblatt KP, Garey KW. Vitamin D Assessment Over 48 Weeks in Treatment-Naive HIV Individuals Starting Lopinavir/Ritonavir Monotherapy. Curr HIV Res. 2021; 19(1):61-72. PMID: 32860360.
      Citations: 2     Fields:    Translation:Humans
    75. Garey KW, Begum K, Lancaster C, Gonzales-Luna A, Bui D, Mercier J, Seng Yue C, Ducharme MP, Hu M, Vince B, Silverman MH, Alam MJ, Kankam M. A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat administered orally to healthy subjects. J Antimicrob Chemother. 2020 12 01; 75(12):3635-3643. PMID: 32892222; PMCID: PMC7662179.
      Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
    76. Asias-Dinh BD, Garey KW. Factors associated with abnormal glucose readings in a pharmacy-led community health fair using the ADA risk assessment tool. J Am Pharm Assoc (2003). 2021 Mar-Apr; 61(2):174-180. PMID: 33257174.
      Citations:    Fields:    Translation:HumansPHPublic Health
    77. Kiles TM, Zhao AV, Wanat MA, Garey KW, Hatfield CL. Knowledge and self-perception comparisons between students with and without prior technician experience in community pharmacy lab courses. Curr Pharm Teach Learn. 2021 03; 13(3):279-287. PMID: 33641739.
      Citations:    Fields:    Translation:Humans
    78. Kiles TM, Garey KW, Wanat MA, Pitman P. A survey to assess experiences and social support of underrepresented minority doctor of pharmacy students. Curr Pharm Teach Learn. 2021 03; 13(3):245-254. PMID: 33641734.
      Citations: 2     Fields:    Translation:Humans
    79. Engevik MA, Danhof HA, Auchtung J, Endres BT, Ruan W, Engevik AC, Wu Q, Nicholson M, Luna RA, Garey KW, Crawford SE, Estes MK, Lux R, Yacyshyn MB, Yacyshyn B, Savidge T, Britton RA, Versalovic J, Bass?res E. Fusobacteriumnucleatum Adheres to Clostridioides difficile via the RadD Adhesin to Enhance Biofilm Formation in Intestinal Mucus. Gastroenterology. 2021 03; 160(4):1301-1314.e8. PMID: 33227279; PMCID: PMC7956072.
      Citations: 11     Fields:    Translation:HumansCells
    80. Thabit AK, Shea KM, Guzman OE, Garey KW. Antibiotic utilization within 18 community hospitals in the United States: A 5-year analysis. Pharmacoepidemiol Drug Saf. 2021 04; 30(4):403-408. PMID: 33094502.
      Citations: 1     Fields:    Translation:HumansCells
    81. Sprague R, Warny K, Pollock N, Daugherty K, Lin Q, Xu H, Cuddemi C, Barrett C, Chen X, Garey KW, Gonzales-Luna AJ, Alonso CD, Galvez JAV, Banz A, Lantz A, Kelly CP. Absence of Toxemia in Clostridioides difficile Infection: Results from Ultrasensitive Toxin Assay of Serum. Dig Dis Sci. 2021 10; 66(10):3303-3306. PMID: 33164145; PMCID: PMC8105423.
      Citations: 2     Fields:    Translation:HumansCells
    82. Carlson TJ, Gonzales-Luna AJ, Nebo K, Chan HY, Tran NT, Antony S, Lancaster C, Alam MJ, Begum K, Garey KW. Assessment of Kidney Injury as a Severity Criteria for Clostridioides Difficile Infection. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa476. PMID: 33209956; PMCID: PMC7652094.
      Citations: 3     
    83. Begum K, Lancaster C, Gonzales-Luna AJ, Carlson TJ, Miranda J, Rashid T, Alam MJ, Eyre DW, Wilcox MH, Garey KW, Bass?res E. In vitro activity of eravacycline against common ribotypes of Clostridioides difficile. J Antimicrob Chemother. 2020 10 01; 75(10):2879-2884. PMID: 32719870; PMCID: PMC7678891.
      Citations:    Fields:    Translation:HumansCells
    84. Garey KW. Perils, Pitfalls, and Promise of Primary Prophylaxis for Clostridioides difficile Infection. Clin Infect Dis. 2020 08 22; 71(5):1140-1141. PMID: 31560048; PMCID: PMC7442846.
      Citations: 2     Fields:    Translation:HumansCells
    85. Engevik MA, Luck B, Visuthranukul C, Ihekweazu FD, Engevik AC, Shi Z, Danhof HA, Chang-Graham AL, Hall A, Endres BT, Haidacher SJ, Horvath TD, Haag AM, Devaraj S, Garey KW, Britton RA, Hyser JM, Shroyer NF, Versalovic J. Human-Derived Bifidobacterium dentium Modulates the Mammalian Serotonergic System and Gut-Brain Axis. Cell Mol Gastroenterol Hepatol. 2021; 11(1):221-248. PMID: 32795610; PMCID: PMC7683275.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    86. Begum K, Miranda J, Lancaster C, Gonzales-Luna AJ, Carlson TJ, Rashid T, Eyre DW, Wilcox MH, Alam MJ, Garey KW, Bass?res E. In Vitro Activity of Omadacycline, a New Tetracycline Analog, and Comparators against Clostridioides difficile. Antimicrob Agents Chemother. 2020 07 22; 64(8). PMID: 32513796; PMCID: PMC7526832.
      Citations: 3     Fields:    Translation:Cells
    87. Lin Q, Pollock NR, Banz A, Lantz A, Xu H, Gu L, Gerding DN, Garey KW, Gonzales-Luna AJ, Zhao M, Song L, Duffy DC, Kelly CP, Chen X. Toxin A-Predominant Pathogenic Clostridioides difficile: A Novel Clinical Phenotype. Clin Infect Dis. 2020 06 10; 70(12):2628-2633. PMID: 31400280; PMCID: PMC7286367.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    88. Dubberke ER, Gerding DN, Garey KW, Rahav G, Mosley A, Tipping R, Dorr MB, Kelly CP. Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection. Open Forum Infect Dis. 2020 Jun; 7(6):ofaa157. PMID: 32523972; PMCID: PMC7264839.
      Citations: 3     
    89. Skoglund E, Fernandez J, Sherer JT, Coyle EA, Garey KW, Fleming ML, Sofjan AK. Using the Theory of Planned Behavior to Evaluate Factors That Influence PharmD Students' Intention to Attend Lectures. Am J Pharm Educ. 2020 05; 84(5):7550. PMID: 32577029; PMCID: PMC7298223.
      Citations: 1     Fields:    Translation:Humans
    90. Shen WJ, Deshpande A, Hevener KE, Endres BT, Garey KW, Palmer KL, Hurdle JG. Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates. J Antimicrob Chemother. 2020 04 01; 75(4):859-867. PMID: 31873741; PMCID: PMC7069472.
      Citations: 9     Fields:    Translation:Cells
    91. Engevik MA, Danhof HA, Chang-Graham AL, Spinler JK, Engevik KA, Herrmann B, Endres BT, Garey KW, Hyser JM, Britton RA, Versalovic J. Human intestinal enteroids as a model of Clostridioides difficile-induced enteritis. Am J Physiol Gastrointest Liver Physiol. 2020 05 01; 318(5):G870-G888. PMID: 32223302; PMCID: PMC7272722.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    92. Hengel RL, Ritter TE, Nathan RV, Van Anglen LJ, Schroeder CP, Dillon RJ, Marcella SW, Garey KW. Real-world Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study. Open Forum Infect Dis. 2020 Apr; 7(4):ofaa097. PMID: 32363211; PMCID: PMC7186524.
      Citations: 10     
    93. Tam VH, Cohen DN, Ledesma KR, Guillory B, Chan K, Garey KW. Local Tissue Response to Subcutaneous Administration of Ceftriaxone in an Animal Model. Antimicrob Agents Chemother. 2020 02 21; 64(3). PMID: 31871078; PMCID: PMC7038272.
      Citations: 1     Fields:    Translation:Animals
    94. Smith DV, Gautreaux S, Gulbis AM, Bruno JJ, Garey K, Roux RK, Varkey D. Program development of a preceptor bootcamp for operational pharmacy preceptors. Am J Health Syst Pharm. 2020 Feb 19; 77(Supplement_1):S2-S7. PMID: 31950136.
      Citations:    Fields:    Translation:Humans
    95. Alosaimy S, Jorgensen SCJ, Lagnf AM, Melvin S, Mynatt RP, Carlson TJ, Garey KW, Allen D, Venugopalan V, Veve M, Athans V, Saw S, Yost CN, Davis SL, Rybak MJ. Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial Infections. Open Forum Infect Dis. 2020 Mar; 7(3):ofaa051. PMID: 32161775; PMCID: PMC7060146.
      Citations: 14     
    96. Gonzales-Luna AJ, Carlson TJ, Dotson KM, Poblete K, Costa G, Miranda J, Lancaster C, Walk ST, Tupy S, Begum K, Alam MJ, Garey KW. PCR ribotypes of Clostridioides difficile across Texas from 2011 to 2018 including emergence of ribotype 255. Emerg Microbes Infect. 2020; 9(1):341-347. PMID: 32037964; PMCID: PMC7033716.
      Citations: 7     Fields:    Translation:HumansCells
    97. Carlson TJ, Endres BT, Le Pham J, Gonzales-Luna AJ, Alnezary FS, Nebo K, Miranda J, Lancaster C, Begum K, Alam MJ, Reveles KR, Garey KW, Bass?res E. Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With Clostridioides difficile Infection. Open Forum Infect Dis. 2020 Jan; 7(1):ofz552. PMID: 31993458; PMCID: PMC6979314.
      Citations: 7     
    98. Rashid T, Haghighi F, Hasan I, Alam MJ, Sharma SV, Lai D, DuPont HL, Garey KW, Bass?res E. Activity of Hospital Disinfectants against Vegetative Cells and Spores of Clostridioides difficile Embedded in Biofilms. Antimicrob Agents Chemother. 2019 12 20; 64(1). PMID: 31611365; PMCID: PMC7187568.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    99. Carlson TJ, Blasingame D, Gonzales-Luna AJ, Alnezary F, Garey KW. Clostridioides difficile ribotype 106: A systematic review of the antimicrobial susceptibility, genetics, and clinical outcomes of this common worldwide strain. Anaerobe. 2020 Apr; 62:102142. PMID: 32007682; PMCID: PMC7153973.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    100. Doern GV, Carroll KC, Diekema DJ, Garey KW, Rupp ME, Weinstein MP, Sexton DJ. Practical Guidance for Clinical Microbiology Laboratories: A Comprehensive Update on the Problem of Blood Culture Contamination and a Discussion of Methods for Addressing the Problem Clin Microbiol Rev. 2019 12 18; 33(1). PMID: 31666280; PMCID: PMC6822992.
      Citations: 29     Fields:    Translation:Humans
    101. Shelburne SA, Dib RW, Endres BT, Reitzel R, Li X, Kalia A, Sahasrabhojane P, Chaftari AM, Hachem R, Vargas-Cruz NS, Jiang Y, Garey K, Fowler VG, Holland TL, Gu J, Miller W, Sakurai A, Arias CA, Aitken SL, Greenberg DE, Kim J, Flores AR, Raad I. Whole-genome sequencing of Staphylococcus epidermidis bloodstream isolates from a prospective clinical trial reveals that complicated bacteraemia is caused by a limited number of closely related sequence types. Clin Microbiol Infect. 2020 May; 26(5):646.e1-646.e8. PMID: 31639470.
      Citations: 6     Fields:    Translation:HumansCells
    102. Spinler JK, Gonzales-Luna AJ, Raza S, Runge JK, Luna RA, Savidge TC, Garey KW. Complete Genome Sequence of Clostridioides difficile Ribotype 255 Strain Mta-79, Assembled Using Oxford Nanopore and Illumina Sequencing. Microbiol Resour Announc. 2019 Oct 17; 8(42). PMID: 31624167; PMCID: PMC6797532.
      Citations: 3     
    103. Vickers RJ, Bassetti M, Clancy CJ, Garey KW, Greenberg DE, Nguyen MH, Roblin D, Tillotson GS, Wilcox MH. Combating resistance while maintaining innovation: the future of antimicrobial stewardship. Future Microbiol. 2019 10; 14:1331-1341. PMID: 31526186.
      Citations: 4     Fields:    Translation:Humans
    104. Sofjan AK, Islam MA, Halder K, Kabir ND, Saleh AA, Miranda J, Lancaster C, Begum K, Alam MJ, Garey KW. Molecular epidemiology of toxigenic Clostridioides difficile isolates from hospitalized patients and the hospital environment in Dhaka, Bangladesh. Anaerobe. 2020 Feb; 61:102081. PMID: 31356958; PMCID: PMC7315644.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    105. Engevik MA, Luk B, Chang-Graham AL, Hall A, Herrmann B, Ruan W, Endres BT, Shi Z, Garey KW, Hyser JM, Versalovic J. Bifidobacterium dentium Fortifies the Intestinal Mucus Layer via Autophagy and Calcium Signaling Pathways. mBio. 2019 06 18; 10(3). PMID: 31213556; PMCID: PMC6581858.
      Citations: 43     Fields:    Translation:AnimalsCells
    106. Endres BT, Begum K, Alam MJ, Garey KW, Rainha K, Fernandes Ferreira R, Trindade CNR, Carneiro LG, Penna B, Domingues Regina Maria CP, Ferreira EO. Characterization of Clostridioides difficile ribotypes in domestic dogs in Rio de Janeiro, Brazil. Anaerobe. 2019 Aug; 58:22-29. PMID: 31220606.
      Citations: 3     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    107. Alam MJ, McPherson J, Miranda J, Thrall A, Ngo V, Kessinger R, Begum K, Marin M, Garey KW. Molecular epidemiology of Clostridioides difficile in domestic dogs and zoo animals. Anaerobe. 2019 Oct; 59:107-111. PMID: 31207298; PMCID: PMC6785390.
      Citations: 1     Fields:    Translation:AnimalsCells
    108. Reveles KR, Dotson KM, Gonzales-Luna A, Surati D, Endres BT, Alam MJ, Garey KW. Clostridioides (Formerly Clostridium) difficile Infection During Hospitalization Increases the Likelihood of Nonhome Patient Discharge. Clin Infect Dis. 2019 05 17; 68(11):1887-1893. PMID: 30204878; PMCID: PMC6522682.
      Citations: 10     Fields:    Translation:Humans
    109. Bhakta SB, Colavecchia AC, Haines L, Varkey D, Garey KW. A systematic approach to optimize electronic health record medication alerts in a health system. Am J Health Syst Pharm. 2019 Apr 08; 76(8):530-536. PMID: 31361861.
      Citations: 5     Fields:    Translation:Humans
    110. Carlson TJ, Endres BT, Gonzales-Luna AJ, Garey KW, Bass?res E. Ridinilazole for the treatment of Clostridioides difficile infection. Expert Opin Investig Drugs. 2019 Apr; 28(4):303-310. PMID: 30767587.
      Citations: 4     Fields:    Translation:HumansCells
    111. Dempsey C, Skoglund E, Muldrew KL, Garey KW. Economic health care costs of blood culture contamination: A systematic review. Am J Infect Control. 2019 08; 47(8):963-967. PMID: 30795840.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    112. Islam MA, Kabir ND, Moniruzzaman M, Begum K, Ahmed D, Faruque ASG, Garey KW, Alam MJ. Clostridioides difficile ribotypes isolated from domestic environment and from patients in Bangladesh. Anaerobe. 2019 Apr; 56:88-90. PMID: 30794875; PMCID: PMC6475596.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    113. Endres BT, Begum K, Sun H, Walk ST, Memariani A, Lancaster C, Gonzales-Luna AJ, Dotson KM, Offiong C, Tupy S, Kuper K, Septimus E, Arafat R, Alam MJ, Zhao Z, Hurdle JG, Savidge TC, Garey KW, Bass?res E. Epidemic Clostridioides difficile Ribotype 027 Lineages: Comparisons of Texas Versus Worldwide Strains. Open Forum Infect Dis. 2019 Feb; 6(2):ofz013. PMID: 30793006; PMCID: PMC6368847.
      Citations: 9     
    114. Yee KL, Kleijn HJ, Kerbusch T, Matthews RP, Dorr MB, Garey KW, Wrishko RE. Population Pharmacokinetics and Pharmacodynamics of Bezlotoxumab in Adults with Primary and Recurrent Clostridium difficile Infection. Antimicrob Agents Chemother. 2019 02; 63(2). PMID: 30455246; PMCID: PMC6355577.
      Citations: 7     Fields:    Translation:HumansCells
    115. Skoglund E, Dempsey CJ, Chen H, Garey KW. Estimated Clinical and Economic Impact through Use of a Novel Blood Collection Device To Reduce Blood Culture Contamination in the Emergency Department: a Cost-Benefit Analysis. J Clin Microbiol. 2019 01; 57(1). PMID: 30355758; PMCID: PMC6322461.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    116. McDonald LC, Johnson S, Bakken JS, Garey KW, Kelly C, Gerding DN. Reply to Fabre et al. Clin Infect Dis. 2018 11 28; 67(12):1958-1959. PMID: 29860268.
      Citations:    Fields:    Translation:Humans
    117. Endres BT, Dotson KM, Poblete K, McPherson J, Lancaster C, Memariani A, Arnold S, Tupy S, Carlsen C, Morehead B, Anyatonwu S, Cook C, Begum K, Alam MJ, Garey KW, Bass?res E. Environmental transmission of Clostridioides difficile ribotype 027 at a long-term care facility; an outbreak investigation guided by whole genome sequencing. Infect Control Hosp Epidemiol. 2018 11; 39(11):1322-1329. PMID: 30253813; PMCID: PMC6423542.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    118. Addo Smith JN, Yau R, Russo HP, Putney K, Restrepo A, Garey KW, Sofjan AK. Bacteremia in Patients With Liver Cirrhosis: Prevalence and Predictors of Multidrug Resistant Organisms. J Clin Gastroenterol. 2018 08; 52(7):648-654. PMID: 29176351.
      Citations: 6     Fields:    Translation:HumansCells
    119. Beyda ND, Amadio J, Rodriguez JR, Malinowski K, Garey KW, Wanger A, Ostrosky-Zeichner L. In Vitro Evaluation of BacT/Alert FA Blood Culture Bottles and T2Candida Assay for Detection of Candida in the Presence of Antifungals. J Clin Microbiol. 2018 08; 56(8). PMID: 29898999; PMCID: PMC6062783.
      Citations: 7     Fields:    Translation:HumansAnimals
    120. Bhakta SB, Colavecchia AC, Coffey W, Curlee DR, Garey KW. Implementation and evaluation of a sterile compounding robot in a satellite oncology pharmacy. Am J Health Syst Pharm. 2018 Jun 01; 75(11 Supplement 2):S51-S57. PMID: 29802179.
      Citations: 1     Fields:    Translation:Humans
    121. Sofjan AK, Musgrove RJ, Beyda ND, Russo HP, Lasco TM, Yau R, Restrepo A, Garey KW. Prevalence and predictors of spontaneous bacterial peritonitis due to ceftriaxone-resistant organisms at a large tertiary centre in the USA. J Glob Antimicrob Resist. 2018 12; 15:41-47. PMID: 29842975.
      Citations: 5     Fields:    Translation:HumansCells
    122. Clancy CJ, Pappas PG, Vazquez J, Judson MA, Kontoyiannis DP, Thompson GR, Garey KW, Reboli A, Greenberg RN, Apewokin S, Lyon GM, Ostrosky-Zeichner L, Wu AHB, Tobin E, Nguyen MH, Caliendo AM. Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel. Clin Infect Dis. 2018 05 17; 66(11):1678-1686. PMID: 29438475.
      Citations: 41     Fields:    Translation:HumansAnimals
    123. Dotson KM, Aitken SL, Sofjan AK, Shah DN, Aparasu RR, Garey KW. Outcomes associated with Clostridium difficile infection in patients with chronic liver disease. Epidemiol Infect. 2018 07; 146(9):1101-1105. PMID: 29739486; PMCID: PMC6057822.
      Citations: 10     Fields:    Translation:Humans
    124. Sofjan AK, Casey BO, Xu BA, Amadio J, Restrepo A, Alam MJ, Garey KW. Accelerate PhenoTestTM BC Kit Versus Conventional Methods for Identification and Antimicrobial Susceptibility Testing of Gram-Positive Bloodstream Isolates: Potential Implications for Antimicrobial Stewardship. Ann Pharmacother. 2018 08; 52(8):754-762. PMID: 29557208.
      Citations: 6     Fields:    Translation:HumansCells
    125. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Shaklee Sammons J, Sandora TJ, Wilcox MH, Loo V. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 03 19; 66(7):987-994. PMID: 29562266.
      Citations: 263     Fields:    
    126. McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, Dubberke ER, Garey KW, Gould CV, Kelly C, Shaklee Sammons J, Sandora TJ, Wilcox MH, Loo V. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 03 19; 66(7):e1-e48. PMID: 29462280; PMCID: PMC6018983.
      Citations: 469     Fields:    Translation:HumansCells
    127. Sofjan AK, Mitchell A, Shah DN, Nguyen T, Sim M, Trojcak A, Beyda ND, Garey KW. Rezafungin (CD101), a next-generation echinocandin: A systematic literature review and assessment of possible place in therapy. J Glob Antimicrob Resist. 2018 09; 14:58-64. PMID: 29486356.
      Citations: 25     Fields:    Translation:HumansAnimals
    128. Davis ML, Sparrow HG, Ikwuagwu JO, Musick WL, Garey KW, Perez KK. Multicentre derivation and validation of a simple predictive index for healthcare-associated Clostridium difficile infection. Clin Microbiol Infect. 2018 Nov; 24(11):1190-1194. PMID: 29454848.
      Citations: 7     Fields:    Translation:HumansCells
    129. Rogers JW, Fleming M, Tipton J, Ward A, Garey KW, Pitman EP. Investigating inpatient medication administration using the theory of planned behavior. Am J Health Syst Pharm. 2017 Dec 15; 74(24):2065-2070. PMID: 29222364.
      Citations: 1     Fields:    Translation:Humans
    130. Rashid T, Poblete K, Amadio J, Hasan I, Begum K, Alam MJ, Garey KW. Evaluation of a shoe sole UVC device to reduce pathogen colonization on floors, surfaces and patients. J Hosp Infect. 2018 Jan; 98(1):96-101. PMID: 29066141.
      Citations: 5     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    131. Yu H, Chen K, Sun Y, Carter M, Garey KW, Savidge TC, Devaraj S, Tessier ME, von Rosenvinge EC, Kelly CP, Pasetti MF, Feng H. Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity. Clin Vaccine Immunol. 2017 Aug; 24(8). PMID: 28592627; PMCID: PMC5583471.
      Citations: 39     Fields:    Translation:HumansCells
    132. Endres B, Rashid T, Chang L, Alam MJ, Garey KW, Bass?res E. A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment. J Vis Exp. 2017 05 25; (123). PMID: 28570548; PMCID: PMC5608145.
      Citations: 2     Fields:    Translation:Cells
    133. Shea KM, Hobbs ALV, Jaso TC, Bissett JD, Cruz CM, Douglass ET, Garey KW. Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection. Antimicrob Agents Chemother. 2017 06; 61(6). PMID: 28348151; PMCID: PMC5444144.
      Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
    134. Endres BT, Alam MJ, Garey KW, Bass?res E. Cadazolid for the treatment of Clostridium difficile. Expert Opin Investig Drugs. 2017 Apr; 26(4):509-514. PMID: 28286992.
      Citations: 9     Fields:    Translation:HumansCells
    135. Alam MJ, Walk ST, Endres BT, Basseres E, Khaleduzzaman M, Amadio J, Musick WL, Christensen JL, Kuo J, Atmar RL, Garey KW. Community Environmental Contamination of Toxigenic Clostridium difficile. Open Forum Infect Dis. 2017; 4(1):ofx018. PMID: 28480289; PMCID: PMC5414050.
      Citations: 17     
    136. Endres BT, Dotson KM, Alam MJ, Garey KW, Bass?res E. Novel antibiotics in development to treat Clostridium difficile infection. Curr Opin Gastroenterol. 2017 01; 33(1):1-7. PMID: 28134686.
      Citations: 4     Fields:    Translation:Humans
    137. Rashid T, Vonville H, Hasan I, Garey KW. Mechanisms for floor surfaces or environmental ground contamination to cause human infection: a systematic review. Epidemiol Infect. 2017 01; 145(2):347-357. PMID: 27780492; PMCID: PMC9507548.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    138. Cox SR, Liebl MG, McComb MN, Chau JQ, Wilson AA, Achi M, Garey KW, Wallace D. Association between health literacy and 30-day healthcare use after hospital discharge in the heart failure population. Res Social Adm Pharm. 2017 Jul - Aug; 13(4):754-758. PMID: 28277275.
      Citations: 6     Fields:    Translation:Humans
    139. Rashid T, VonVille HM, Hasan I, Garey KW. Shoe soles as a potential vector for pathogen transmission: a systematic review. J Appl Microbiol. 2016 Nov; 121(5):1223-1231. PMID: 27495010.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    140. Aitken SL, Gschwind L, Goddu S, Xie Y, Duff C, Shah DN, DuPont HL, Garey KW, Barbut F. Development and Validation of a Clostridium difficile Health-related Quality-of-Life Questionnaire. J Clin Gastroenterol. 2016 09; 50(8):631-7. PMID: 26796081; PMCID: PMC4978607.
      Citations: 12     Fields:    Translation:HumansCells
    141. Shah DN, Chan FS, Kachru N, Garcia KP, Balcer HE, Dyer AP, Emanuel JE, Jordan MD, Lusardi KT, Naymick G, Polisetty RS, Sieman L, Tyler AM, Johnson ML, Garey KW. A multi-center study of fidaxomicin use for Clostridium difficile infection. Springerplus. 2016; 5(1):1224. PMID: 27536508; PMCID: PMC4970984.
      Citations: 2     
    142. Gorbach C, Blanton L, Lukawski B, Varkey AC, Pitman P, Garey KW. Benchmarking and medication error rates. Am J Health Syst Pharm. 2016 Jun 01; 73(11):746. PMID: 27208057.
      Citations:    Fields:    Translation:Humans
    143. Vickers RJ, Tillotson G, Goldstein EJ, Citron DM, Garey KW, Wilcox MH. Ridinilazole: a novel therapy for Clostridium difficile infection. Int J Antimicrob Agents. 2016 Aug; 48(2):137-43. PMID: 27283730.
      Citations: 13     Fields:    Translation:HumansCells
    144. Endres BT, Khaleduzzaman M, Alam MJ, Chesnel L, Garey KW, Bass?res E. Evaluating the Effects of Surotomycin Treatment on Clostridium difficile Toxin A and B Production, Immune Response, and Morphological Changes. Antimicrob Agents Chemother. 2016 06; 60(6):3519-23. PMID: 27021314; PMCID: PMC4879405.
      Citations: 5     Fields:    Translation:HumansCells
    145. Endres BT, Memariani A, Chang L, Alam MJ, Vickers RJ, Kakadiaris IA, Garey KW, Bass?res E. A novel method for imaging the pharmacological effects of antibiotic treatment on Clostridium difficile. Anaerobe. 2016 Aug; 40:10-4. PMID: 27108094.
      Citations: 1     Fields:    Translation:Cells
    146. Shah DN, Aitken SL, Barragan LF, Bozorgui S, Goddu S, Navarro ME, Xie Y, DuPont HL, Garey KW. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study. J Hosp Infect. 2016 Jul; 93(3):286-9. PMID: 27209056.
      Citations: 17     Fields:    Translation:HumansCells
    147. Thabit AK, Alam MJ, Khaleduzzaman M, Garey KW, Nicolau DP. A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin. Ann Clin Microbiol Antimicrob. 2016 Apr 12; 15:22. PMID: 27071986; PMCID: PMC4830079.
      Citations: 3     Fields:    Translation:HumansCells
    148. Endres BT, Khaleduzzaman M, Miraftabi F, Alam MJ, Vickers RJ, Garey KW, Bass?res E. Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection. J Antimicrob Chemother. 2016 May; 71(5):1245-51. PMID: 26895772; PMCID: PMC4830417.
      Citations: 19     Fields:    Translation:HumansCells
    149. Philip A, Desai A, Nguyen PA, Birney P, Colavecchia A, Karralli R, Smith L, Lorimer D, Burgess G, Munch K, Daniel N, Lionetti J, Garey KW. Evaluating pharmacy leader development through the seven action logics. Am J Health Syst Pharm. 2016 Jan 15; 73(2):82-5. PMID: 26721538.
      Citations: 2     Fields:    Translation:Humans
    150. Sayles C, Hickerson SC, Bhat RR, Hall J, Garey KW, Trivedi MV. Oral Glutamine in Preventing Treatment-Related Mucositis in Adult Patients With Cancer: A Systematic Review. Nutr Clin Pract. 2016 Apr; 31(2):171-9. PMID: 26507188.
      Citations: 19     Fields:    Translation:Humans
    151. Gorbach C, Blanton L, Lukawski BA, Varkey AC, Pitman EP, Garey KW. Frequency of and risk factors for medication errors by pharmacists during order verification in a tertiary care medical center. Am J Health Syst Pharm. 2015 Sep 01; 72(17):1471-4. PMID: 26294240.
      Citations: 3     Fields:    Translation:Humans
    152. Aitken SL, Alam MJ, Khaleduzzaman M, Khaleduzzuman M, Walk ST, Musick WL, Pham VP, Christensen JL, Atmar RL, Xie Y, Garey KW. In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent. Infect Control Hosp Epidemiol. 2015 Nov; 36(11):1318-23. PMID: 26288985; PMCID: PMC4710480.
      Citations: 18     Fields:    Translation:HumansCells
    153. Pham VP, Luce AM, Ruppelt SC, Wei W, Aitken SL, Musick WL, Roux RK, Garey KW. Age-Stratified Treatment Response Rates in Hospitalized Patients with Clostridium difficile Infection Treated with Metronidazole. Antimicrob Agents Chemother. 2015 Oct; 59(10):6113-6. PMID: 26195522; PMCID: PMC4576055.
      Citations: 4     Fields:    Translation:HumansCells
    154. Blee J, Roux RK, Gautreaux S, Sherer JT, Garey KW. Dispensing inhalers to patients with chronic obstructive pulmonary disease on hospital discharge: Effects on prescription filling and readmission. Am J Health Syst Pharm. 2015 Jul 15; 72(14):1204-8. PMID: 26150570.
      Citations: 6     Fields:    Translation:Humans
    155. Beyda ND, Liao G, Endres BT, Lewis RE, Garey KW. Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates. Antimicrob Agents Chemother. 2015 Sep; 59(9):5405-12. PMID: 26100700; PMCID: PMC4538525.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    156. Philip A, Gessner-Wharton M, Birney P, Blee J, Desai A, Gorbach C, Karralli R, Lorimer D, Munch K, Nweke G, Parekh S, Puebla M, Cox R, Pitman EP, Garey KW. Pharmacy Practice Model Initiative task force report: Improving participation in a survey on hospital pharmacy practices in Texas. Am J Health Syst Pharm. 2015 Jun 15; 72(12):1053-7. PMID: 26025997.
      Citations: 1     Fields:    Translation:Humans
    157. Nesher L, Hadi CM, Salazar L, Wootton SH, Garey KW, Lasco T, Luce AM, Hasbun R. Epidemiology of meningitis with a negative CSF Gram stain: under-utilization of available diagnostic tests. Epidemiol Infect. 2016 Jan; 144(1):189-97. PMID: 25989841; PMCID: PMC9507288.
      Citations: 14     Fields:    Translation:Humans
    158. Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, Groeger JS, Judson MA, Vinagre YM, Heard SO, Zervou FN, Zacharioudakis IM, Kontoyiannis DP, Pappas PG. Reply to Bauer and Goff. Clin Infect Dis. 2015 Aug 01; 61(3):487-8. PMID: 25944341.
      Citations: 1     Fields:    Translation:HumansAnimals
    159. Na X, Martin AJ, Sethi S, Kyne L, Garey KW, Flores SW, Hu M, Shah DN, Shields K, Leffler DA, Kelly CP. A Multi-Center Prospective Derivation and Validation of a Clinical Prediction Tool for Severe Clostridium difficile Infection. PLoS One. 2015; 10(4):e0123405. PMID: 25906284; PMCID: PMC4408056.
      Citations: 17     Fields:    Translation:HumansCells
    160. Yu H, Chen K, Wu J, Yang Z, Shi L, Barlow LL, Aronoff DM, Garey KW, Savidge TC, von Rosenvinge EC, Kelly CP, Feng H. Identification of toxemia in patients with Clostridium difficile infection. PLoS One. 2015; 10(4):e0124235. PMID: 25885671; PMCID: PMC4401762.
      Citations: 19     Fields:    Translation:HumansAnimalsCells
    161. Philip A, Green M, Hoffman T, Gautreaux S, Wallace D, Roux R, Garey KW. Expansion of clinical pharmacy through increased use of outpatient pharmacists for anticoagulation services. Am J Health Syst Pharm. 2015 Apr 01; 72(7):568-72. PMID: 25788511.
      Citations: 3     Fields:    Translation:Humans
    162. Kilic A, Alam MJ, Tisdel NL, Shah DN, Yapar M, Lasco TM, Garey KW. Multiplex Real-Time PCR Method for Simultaneous Identification and Toxigenic Type Characterization of Clostridium difficile From Stool Samples. Ann Lab Med. 2015 May; 35(3):306-13. PMID: 25932438; PMCID: PMC4390698.
      Citations: 6     Fields:    Translation:HumansCells
    163. Garey KW, Aitken SL, Dima-Ala A, Beyda ND, Kuper K, Xie Y, Koo HL. Echinocandin use in hospitalized patients: a multi-institutional study. Am J Med Sci. 2015 Apr; 349(4):316-20. PMID: 25607510.
      Citations: 1     Fields:    Translation:Humans
    164. Martinson JN, Broadaway S, Lohman E, Johnson C, Alam MJ, Khaleduzzaman M, Garey KW, Schlackman J, Young VB, Santhosh K, Rao K, Lyons RH, Walk ST. Evaluation of portability and cost of a fluorescent PCR ribotyping protocol for Clostridium difficile epidemiology. J Clin Microbiol. 2015 Apr; 53(4):1192-7. PMID: 25631804; PMCID: PMC4365229.
      Citations: 27     Fields:    Translation:HumansCells
    165. Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, Garey KW, Alangaden GJ, Vazquez JA, Groeger JS, Judson MA, Vinagre YM, Heard SO, Zervou FN, Zacharioudakis IM, Kontoyiannis DP, Pappas PG. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis. 2015 Mar 15; 60(6):892-9. PMID: 25586686.
      Citations: 112     Fields:    Translation:HumansAnimalsCTClinical Trials
    166. Jacobs DM, Kuper K, Septimus E, Arafat R, Garey KW. Assessment of Antimicrobial Stewardship Activities in a Large Metropolitan Area. J Pharm Pract. 2016 Jun; 29(3):188-93. PMID: 25312262.
      Citations: 2     Fields:    Translation:Humans
    167. Aitken SL, Hemmige VS, Koo HL, Vuong NN, Lasco TM, Garey KW. Real-world performance of a microarray-based rapid diagnostic for Gram-positive bloodstream infections and potential utility for antimicrobial stewardship. Diagn Microbiol Infect Dis. 2015 Jan; 81(1):4-8. PMID: 25445120.
      Citations: 11     Fields:    Translation:HumansCells
    168. Bernhardt MB, Moffett BS, Johnson M, Tam VH, Thompson P, Garey KW. Agreement among measurements and estimations of glomerular filtration in children with cancer. Pediatr Blood Cancer. 2015 Jan; 62(1):80-4. PMID: 25263332.
      Citations: 5     Fields:    Translation:HumansCTClinical Trials
    169. Jacobs DM, Beyda ND, Asuphon O, Alam MJ, Garey KW. Host factors and clinical outcomes of Candida colonization in critically ill patients. Mycopathologia. 2015 Feb; 179(1-2):87-93. PMID: 25173925.
      Citations: 4     Fields:    Translation:HumansAnimals
    170. Aitken SL, Joseph TB, Shah DN, Lasco TM, Palmer HR, DuPont HL, Xie Y, Garey KW. Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas. PLoS One. 2014; 9(7):e102848. PMID: 25057871; PMCID: PMC4109955.
      Citations: 7     Fields:    Translation:HumansCells
    171. Wanat MA, Fleming ML, Fernandez JM, Garey KW. Education, training, and academic experience of newly hired, first-time pharmacy faculty members. Am J Pharm Educ. 2014 Jun 17; 78(5):92. PMID: 24954932; PMCID: PMC4064492.
      Citations: 5     Fields:    Translation:Humans
    172. Beyda ND, John J, Kilic A, Alam MJ, Lasco TM, Garey KW. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clin Infect Dis. 2014 Sep 15; 59(6):819-25. PMID: 24879785.
      Citations: 65     Fields:    Translation:HumansAnimals
    173. Koo HL, Van JN, Zhao M, Ye X, Revell PA, Jiang ZD, Grimes CZ, Koo DC, Lasco T, Kozinetz CA, Garey KW, DuPont HL. Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates. Infect Control Hosp Epidemiol. 2014 Jun; 35(6):667-73. PMID: 24799643.
      Citations: 40     Fields:    Translation:HumansCellsPHPublic Health
    174. Aitken SL, Beyda ND, Shah DN, Palmer HR, Lasco TM, Koo H, Garey KW. Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics. Ann Pharmacother. 2014 Jun; 48(6):683-90. PMID: 24687545.
      Citations: 7     Fields:    Translation:HumansAnimals
    175. Alam MJ, Anu A, Walk ST, Garey KW. Investigation of potentially pathogenic Clostridium difficile contamination in household environs. Anaerobe. 2014 Jun; 27:31-3. PMID: 24657158.
      Citations: 26     Fields:    Translation:HumansCellsPHPublic Health
    176. Darkoh C, Turnwald BP, Koo HL, Garey KW, Jiang ZD, Aitken SL, DuPont HL. Colonic immunopathogenesis of Clostridium difficile infections. Clin Vaccine Immunol. 2014 Apr; 21(4):509-17. PMID: 24477852; PMCID: PMC3993122.
      Citations: 10     Fields:    Translation:HumansCells
    177. Wanat MA, Garey KW. A blueprint for transitioning pharmacy residents into successful clinical faculty members in colleges and schools of pharmacy. Am J Pharm Educ. 2013 Nov 12; 77(9):200. PMID: 24249862; PMCID: PMC3831411.
      Citations: 7     Fields:    Translation:Humans
    178. Beyda ND, Alam MJ, Garey KW. Comparison of the T2Dx instrument with T2Candida assay and automated blood culture in the detection of Candida species using seeded blood samples. Diagn Microbiol Infect Dis. 2013 Dec; 77(4):324-6. PMID: 24135411.
      Citations: 16     Fields:    Translation:HumansAnimals
    179. Patel TS, Crutchley RD, Tucker AM, Cottreau J, Garey KW. Crofelemer for the treatment of chronic diarrhea in patients living with HIV/AIDS. HIV AIDS (Auckl). 2013; 5:153-62. PMID: 23888120; PMCID: PMC3722035.
      Citations: 7     
    180. Jardin CG, Palmer HR, Shah DN, Le F, Beyda ND, Jiang Z, Garey KW. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy. J Hosp Infect. 2013 Sep; 85(1):28-32. PMID: 23834988.
      Citations: 13     Fields:    Translation:HumansCells
    181. Huang JS, Jiang ZD, Garey KW, Lasco T, Dupont HL. Use of rifamycin drugs and development of infection by rifamycin-resistant strains of Clostridium difficile. Antimicrob Agents Chemother. 2013 Jun; 57(6):2690-3. PMID: 23545528; PMCID: PMC3716149.
      Citations: 14     Fields:    Translation:HumansCells
    182. Yeo QM, Crutchley R, Cottreau J, Tucker A, Garey KW. Crofelemer, a novel antisecretory agent approved for the treatment of HIV-associated diarrhea. Drugs Today (Barc). 2013 Apr; 49(4):239-52. PMID: 23616951.
      Citations: 6     Fields:    Translation:HumansAnimals
    183. Shah DN, Bhatt NS, Welch JK, Koo HL, Garey KW. Defining acute renal dysfunction as a criterion for the severity of Clostridium difficile infection in patients with community-onset vs hospital-onset infection. J Hosp Infect. 2013 Apr; 83(4):294-9. PMID: 23433867; PMCID: PMC3984400.
      Citations: 8     Fields:    Translation:Humans
    184. Jiang ZD, Hoang LN, Lasco TM, Garey KW, Dupont HL. Physician attitudes toward the use of fecal transplantation for recurrent Clostridium difficile infection in a metropolitan area. Clin Infect Dis. 2013 Apr; 56(7):1059-60. PMID: 23223589.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    185. Haines LA, Putney KS, Varkey DA, Frost C, Pitman EP, Aparasu RR, Garey KW. Pilot of a patient-centered pharmacy practice model. Am J Health Syst Pharm. 2012 Nov 01; 69(21):1860-1. PMID: 23111668.
      Citations:    Fields:    Translation:Humans
    186. Beyda ND, Chuang SH, Alam MJ, Shah DN, Ng TM, McCaskey L, Garey KW. Treatment of Candida famata bloodstream infections: case series and review of the literature. J Antimicrob Chemother. 2013 Feb; 68(2):438-43. PMID: 23085777.
      Citations: 20     Fields:    Translation:HumansAnimals
    187. Beyda ND, Lewis RE, Garey KW. Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches. Ann Pharmacother. 2012 Jul-Aug; 46(7-8):1086-96. PMID: 22811350.
      Citations: 32     Fields:    Translation:HumansAnimals
    188. Singh V, Arora V, Alam MJ, Garey KW. Inhibition of biofilm formation by esomeprazole in Pseudomonas aeruginosa and Staphylococcus aureus. Antimicrob Agents Chemother. 2012 Aug; 56(8):4360-4. PMID: 22664967; PMCID: PMC3421605.
      Citations: 7     Fields:    Translation:Cells
    189. Tran TT, Palmer HR, Weston J, Hirsch EB, Shah DN, Cottreau J, Tam VH, Garey KW. Evaluation of a daptomycin dose-optimization protocol. Am J Health Syst Pharm. 2012 Jun 01; 69(11):979-84. PMID: 22610031.
      Citations: 4     Fields:    Translation:Humans
    190. Mora AL, Salazar M, Pablo-Caeiro J, Frost CP, Yadav Y, DuPont HL, Garey KW. Moderate to high use of opioid analgesics are associated with an increased risk of Clostridium difficile infection. Am J Med Sci. 2012 Apr; 343(4):277-80. PMID: 21934595.
      Citations: 17     Fields:    Translation:HumansCells
    191. Shah DN, Yau R, Lasco TM, Weston J, Salazar M, Palmer HR, Garey KW. Impact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia. Antimicrob Agents Chemother. 2012 Jun; 56(6):3239-43. PMID: 22411611; PMCID: PMC3370796.
      Citations: 19     Fields:    Translation:HumansAnimals
    192. Cottreau J, Tucker A, Crutchley R, Garey KW. Crofelemer for the treatment of secretory diarrhea. Expert Rev Gastroenterol Hepatol. 2012 Feb; 6(1):17-23. PMID: 22149578.
      Citations: 14     Fields:    Translation:Humans
    193. Le F, Arora V, Shah DN, Salazar M, Palmer HR, Garey KW. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs. Pharmacotherapy. 2012 Feb; 32(2):129-34. PMID: 22392421.
      Citations: 4     Fields:    Translation:HumansCells
    194. Weston J, Gentry L, Salazar M, Putney K, Frost C, Tipton JA, Cottreau J, Tam VH, Garey KW, Palmer HR. Improving patient care through implementation of an antimicrobial stewardship program. Am J Health Syst Pharm. 2011 Nov 15; 68(22):2170-4. PMID: 22058103.
      Citations: 5     Fields:    Translation:Humans
    195. Crutchley RD, Gathe J, Mayberry C, Trieu A, Abughosh S, Garey KW. Risk factors for vitamin D deficiency in HIV-infected patients in the south central United States. AIDS Res Hum Retroviruses. 2012 May; 28(5):454-9. PMID: 21878055.
      Citations: 8     Fields:    Translation:Humans
    196. Garey KW, Ghantoji SS, Shah DN, Habib M, Arora V, Jiang ZD, DuPont HL. A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. J Antimicrob Chemother. 2011 Dec; 66(12):2850-5. PMID: 21948965.
      Citations: 51     Fields:    Translation:HumansCellsPHPublic Health
    197. Santimaleeworagun W, Wongpoowarak P, Chayakul P, Pattharachayakul S, Tansakul P, Garey KW. In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases. Southeast Asian J Trop Med Public Health. 2011 Jul; 42(4):890-900. PMID: 22299471.
      Citations: 24     Fields:    Translation:HumansCells
    198. Santimaleeworagun W, Wongpoowarak P, Chayakul P, Pattharachayakul S, Tansakul P, Garey KW. Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy. J Med Assoc Thai. 2011 Jul; 94(7):863-70. PMID: 21774295.
      Citations: 7     Fields:    Translation:HumansCells
    199. Shah DN, Yau R, Weston J, Lasco TM, Salazar M, Palmer HR, Garey KW. Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes. J Antimicrob Chemother. 2011 Sep; 66(9):2146-51. PMID: 21700622.
      Citations: 18     Fields:    Translation:HumansAnimals
    200. Arora V, Kachroo S, Ghantoji SS, Dupont HL, Garey KW. High Horn's index score predicts poor outcomes in patients with Clostridium difficile infection. J Hosp Infect. 2011 Sep; 79(1):23-6. PMID: 21700363.
      Citations: 12     Fields:    Translation:HumansCells
    201. Halton K, Arora V, Singh V, Ghantoji SS, Shah DN, Garey KW. Bacterial colonization on writing pens touched by healthcare professionals and hospitalized patients with and without cleaning the pen with alcohol-based hand sanitizing agent. Clin Microbiol Infect. 2011 Jun; 17(6):868-9. PMID: 21463395.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    202. Sethi S, Garey KW, Arora V, Ghantoji S, Rowan P, Smolensky M, DuPont HL. Increased rate of irritable bowel syndrome and functional gastrointestinal disorders after Clostridium difficile infection. J Hosp Infect. 2011 Feb; 77(2):172-3. PMID: 21190754.
      Citations: 10     Fields:    Translation:Humans
    203. Garey KW, Jiang ZD, Ghantoji S, Tam VH, Arora V, Dupont HL. A common polymorphism in the interleukin-8 gene promoter is associated with an increased risk for recurrent Clostridium difficile infection. Clin Infect Dis. 2010 Dec 15; 51(12):1406-10. PMID: 21058913.
      Citations: 36     Fields:    Translation:HumansCells
    204. Bhagunde P, Chang KT, Singh R, Singh V, Garey KW, Nikolaou M, Tam VH. Mathematical modeling to characterize the inoculum effect. Antimicrob Agents Chemother. 2010 Nov; 54(11):4739-43. PMID: 20805390; PMCID: PMC2976129.
      Citations: 7     Fields:    Translation:Cells
    205. Palmer HR, Cottreau JM, Garey KW, Hirsch EB, Musick WL, Tam VH, Yeh RF, Houston Infectious Diseases Network. Significant publications on infectious diseases pharmacotherapy in 2009. Am J Health Syst Pharm. 2010 Aug; 67(15):e34-42. PMID: 20651305.
      Citations:    Fields:    Translation:Humans
    206. Dupont HL, Garey KW. Clostridium difficile infection: an emerging epidemic with more questions than answers. Future Microbiol. 2010 Aug; 5(8):1153-6. PMID: 20722592.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    207. Koo HL, Garey KW, Dupont HL. Future novel therapeutic agents for Clostridium difficile infection. Expert Opin Investig Drugs. 2010 Jul; 19(7):825-36. PMID: 20521993; PMCID: PMC3159574.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    208. Cottreau J, Baker SF, DuPont HL, Garey KW. Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections. Expert Rev Anti Infect Ther. 2010 Jul; 8(7):747-60. PMID: 20586560.
      Citations: 6     Fields:    Translation:Humans
    209. Tam VH, Rogers CA, Chang KT, Weston JS, Caeiro JP, Garey KW. Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes. Antimicrob Agents Chemother. 2010 Sep; 54(9):3717-22. PMID: 20585122; PMCID: PMC2935002.
      Citations: 57     Fields:    Translation:HumansCells
    210. Shah D, Dang MD, Hasbun R, Koo HL, Jiang ZD, DuPont HL, Garey KW. Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance. Expert Rev Anti Infect Ther. 2010 May; 8(5):555-64. PMID: 20455684; PMCID: PMC3138198.
      Citations: 46     Fields:    Translation:HumansCells
    211. Crutchley RD, Miller J, Garey KW. Crofelemer, a novel agent for treatment of secretory diarrhea. Ann Pharmacother. 2010 May; 44(5):878-84. PMID: 20388859.
      Citations: 8     Fields:    Translation:Humans
    212. Jiang ZD, DuPont HL, La Rocco M, Garey KW. In vitro susceptibility of Clostridium difficile to rifaximin and rifampin in 359 consecutive isolates at a university hospital in Houston, Texas. J Clin Pathol. 2010 Apr; 63(4):355-8. PMID: 20354207.
      Citations: 14     Fields:    Translation:HumansCells
    213. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect. 2010 Apr; 74(4):309-18. PMID: 20153547.
      Citations: 115     Fields:    Translation:HumansCells
    214. Birtcher KK, Corbett SM, Pass SE, Coyle EA, Yeh RF, Tipton J, Garey KW, Academic Pharmacy Symposium. Symposium on roles of and cooperation between academic- and practice-based pharmacy clinicians. Am J Health Syst Pharm. 2010 Feb 01; 67(3):231-8. PMID: 20101067.
      Citations: 3     Fields:    Translation:Humans
    215. Tam VH, Chang KT, Abdelraouf K, Brioso CG, Ameka M, McCaskey LA, Weston JS, Caeiro JP, Garey KW. Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2010 Mar; 54(3):1160-4. PMID: 20086165; PMCID: PMC2826008.
      Citations: 43     Fields:    Translation:HumansCells
    216. Salazar M, Baskin L, Garey KW, DuPont HL. Clostridium difficile-related death rates in Texas 1999-2005. J Infect. 2009 Nov; 59(5):303-7. PMID: 19735673.
      Citations: 3     Fields:    Translation:HumansCells
    217. Salazar M, Garey KW, Jiang ZD, Dao-Tran T, DuPont H. Changing Clostridium difficile infection testing and treatment trends at a large tertiary care teaching hospital. Pharm World Sci. 2009 Oct; 31(5):565. PMID: 19657721.
      Citations: 3     Fields:    Translation:HumansCells
    218. Yadav Y, Garey KW, Dao-Tran TK, Kaila V, Gbito KY, DuPont HL. Automated system to identify Clostridium difficile infection among hospitalised patients. J Hosp Infect. 2009 Aug; 72(4):337-41. PMID: 19596490.
      Citations: 1     Fields:    Translation:HumansCells
    219. Jiang ZD, Dupont HL, La Rocco M, Garey KW. WITHDRAWN: In vitro activity of rifaximin and rifampin against clinical isolates of clostridium difficile in houston, texas. Anaerobe. 2009 Feb 15. PMID: 19223017.
      Citations:    Fields:    
    220. Tam VH, Chang KT, Schilling AN, LaRocco MT, Genty LO, Garey KW. Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia. Diagn Microbiol Infect Dis. 2009 Mar; 63(3):279-85. PMID: 19135330.
      Citations: 7     Fields:    Translation:HumansCells
    221. Garey KW, Jiang ZD, Bellard A, Dupont HL. Rifaximin in treatment of recurrent Clostridium difficile-associated diarrhea: an uncontrolled pilot study. J Clin Gastroenterol. 2009 Jan; 43(1):91-3. PMID: 18385603.
      Citations: 29     Fields:    Translation:HumansCellsCTClinical Trials
    222. Garey KW, Vo QP, Larocco MT, Gentry LO, Tam VH. Prevalence of type III secretion protein exoenzymes and antimicrobial susceptibility patterns from bloodstream isolates of patients with Pseudomonas aeruginosa bacteremia. J Chemother. 2008 Dec; 20(6):714-20. PMID: 19129069.
      Citations: 20     Fields:    Translation:HumansCells
    223. Yeh RF, Kuper KM, Coyle EA, Garey KW, Ikwuagwu JO, Maclayton DO, Mohr JF, Musick WL, Pass SE, Rios E, Tam VH, Houston Infectious Disease Network. Significant publications on infectious diseases pharmacotherapy in 2007. Am J Health Syst Pharm. 2008 Nov 15; 65(22):e72-9. PMID: 18997127.
      Citations:    Fields:    Translation:Humans
    224. Garey KW, Vo QP, Lewis RE, Saengcharoen W, LaRocco MT, Tam VH. Increased bacterial adherence and biomass in Pseudomonas aeruginosa bacteria exposed to clarithromycin. Diagn Microbiol Infect Dis. 2009 Jan; 63(1):81-6. PMID: 18990530.
      Citations: 8     Fields:    Translation:Cells
    225. Garey KW, Sethi S, Yadav Y, DuPont HL. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect. 2008 Dec; 70(4):298-304. PMID: 18951661.
      Citations: 122     Fields:    Translation:HumansCells
    226. DuPont HL, Garey K, Caeiro JP, Jiang ZD. New advances in Clostridium difficile infection: changing epidemiology, diagnosis, treatment and control. Curr Opin Infect Dis. 2008 Oct; 21(5):500-7. PMID: 18725800.
      Citations: 18     Fields:    Translation:HumansCells
    227. Garey KW, Martorell MV, Vo QP, Tam VH. Killing activity of rifampin with piperacillin therapy against adherent cells of Pseumodomas aeruginosa. J Chemother. 2008 Oct; 20(5):652-4. PMID: 19028631.
      Citations: 1     Fields:    Translation:HumansCells
    228. Garey KW, Dao-Tran TK, Jiang ZD, Price MP, Gentry LO, Dupont HL. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics. J Hosp Infect. 2008 Oct; 70(2):142-7. PMID: 18723249.
      Citations: 23     Fields:    Translation:HumansCells
    229. Garey KW, Jiang ZD, Yadav Y, Mullins B, Wong K, Dupont HL. Peripartum Clostridium difficile infection: case series and review of the literature. Am J Obstet Gynecol. 2008 Oct; 199(4):332-7. PMID: 18639213.
      Citations: 9     Fields:    Translation:HumansCells
    230. Garey KW, Amrutkar P, Dao-Tran TK, Frost CP, Chen H, Essien EJ, Gentry LO. Economic benefit of appropriate timing of vancomycin prophylaxis in patients undergoing cardiovascular surgery. Pharmacotherapy. 2008 Jun; 28(6):699-706. PMID: 18503397.
      Citations: 1     Fields:    Translation:Humans
    231. Garey KW, Salazar M, Shah D, Rodrigue R, DuPont HL. Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea. Ann Pharmacother. 2008 Jun; 42(6):827-35. PMID: 18430792.
      Citations: 20     Fields:    Translation:HumansCells
    232. Tam VH, Gamez EA, Weston JS, Gerard LN, Larocco MT, Caeiro JP, Gentry LO, Garey KW. Outcomes of bacteremia due to Pseudomonas aeruginosa with reduced susceptibility to piperacillin-tazobactam: implications on the appropriateness of the resistance breakpoint. Clin Infect Dis. 2008 Mar 15; 46(6):862-7. PMID: 18279040.
      Citations: 26     Fields:    Translation:HumansCells
    233. Lim TP, Garey KW, Tam VH. Pharmacokinetic/Pharmacodynamic antimicrobial individualization and optimization strategies. Curr Infect Dis Rep. 2008 Mar; 10(1):9-13. PMID: 18377809.
      Citations:    
    234. Garey KW, Lai D, Dao-Tran TK, Gentry LO, Hwang LY, Davis BR. Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery. Antimicrob Agents Chemother. 2008 Feb; 52(2):446-51. PMID: 18025116; PMCID: PMC2224787.
      Citations: 11     Fields:    Translation:HumansCells
    235. Garey KW, Pai MP, Suda KJ, Turpin RS, Rege MD, Mingo DE, Bearden DT. Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines. Pharmacoepidemiol Drug Saf. 2007 Aug; 16(8):919-27. PMID: 17286303.
      Citations: 14     Fields:    Translation:HumansAnimals
    236. Jiang ZD, Garey KW, Price M, Graham G, Okhuysen P, Dao-Tran T, LaRocco M, DuPont HL. Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea. Clin Gastroenterol Hepatol. 2007 Aug; 5(8):964-8. PMID: 17618838.
      Citations: 18     Fields:    Translation:HumansCells
    237. Tam VH, Chang KT, LaRocco MT, Schilling AN, McCauley SK, Poole K, Garey KW. Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2007 Jul; 58(3):309-14. PMID: 17617302.
      Citations: 14     Fields:    Translation:HumansCells
    238. Loughlin SM, Mortazavi A, Garey KW, Rice GK, Birtcher KK. Pharmacist-managed vaccination program increased influenza vaccination rates in cardiovascular patients enrolled in a secondary prevention lipid clinic. Pharmacotherapy. 2007 May; 27(5):729-33. PMID: 17461708.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    239. Chen H, Suda KJ, Turpin RS, Pai MP, Bearden DT, Garey KW. High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysis. Curr Med Res Opin. 2007 May; 23(5):1057-65. PMID: 17519072.
      Citations: 5     Fields:    Translation:Humans
    240. Tam VH, Schilling AN, LaRocco MT, Gentry LO, Lolans K, Quinn JP, Garey KW. Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa. Clin Microbiol Infect. 2007 Apr; 13(4):413-8. PMID: 17359326.
      Citations: 21     Fields:    Translation:HumansCells
    241. Garey KW, Turpin RS, Bearden DT, Pai MP, Suda KJ. Economic analysis of inadequate fluconazole therapy in non-neutropenic patients with candidaemia: a multi-institutional study. Int J Antimicrob Agents. 2007 May; 29(5):557-62. PMID: 17341444.
      Citations: 7     Fields:    Translation:Humans
    242. Itokazu GS, Schwartz DN, Garey KW, Rodvold KA, Danziger LH, Weinstein RA. Pharmacists' perceptions of the effectiveness of antimicrobial control programs. Am J Health Syst Pharm. 2006 Dec 15; 63(24):2504-8. PMID: 17158699.
      Citations: 1     Fields:    Translation:Humans
    243. Price MF, Dao-Tran T, Garey KW, Graham G, Gentry LO, Dhungana L, Dupont HL. Epidemiology and incidence of Clostridium difficile-associated diarrhoea diagnosed upon admission to a university hospital. J Hosp Infect. 2007 Jan; 65(1):42-6. PMID: 17145108.
      Citations: 11     Fields:    Translation:HumansCells
    244. Amrutkar PP, Rege MD, Chen H, LaRocco MT, Gentry LO, Garey KW. Comparison of risk factors for candidemia versus bacteremia in hospitalized patients. Infection. 2006 Dec; 34(6):322-7. PMID: 17180586.
      Citations: 4     Fields:    Translation:Humans
    245. Pai MP, Turpin RS, Garey KW. Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia. Antimicrob Agents Chemother. 2007 Jan; 51(1):35-9. PMID: 17101684; PMCID: PMC1797664.
      Citations: 49     Fields:    Translation:HumansAnimals
    246. Maclayton DO, Suda KJ, Coval KA, York CB, Garey KW. Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis. Clin Ther. 2006 Aug; 28(8):1208-1216. PMID: 16982298.
      Citations: 38     Fields:    Translation:HumansCells
    247. Garey KW, Kumar N, Dao T, Tam VH, Gentry LO. Risk factors for postoperative chest wound infections due to gram-negative bacteria in cardiac surgery patients. J Chemother. 2006 Aug; 18(4):402-8. PMID: 17024796.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    248. Garey KW, Dao T, Chen H, Amrutkar P, Kumar N, Reiter M, Gentry LO. Timing of vancomycin prophylaxis for cardiac surgery patients and the risk of surgical site infections. J Antimicrob Chemother. 2006 Sep; 58(3):645-50. PMID: 16807254.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    249. Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006 Jul 01; 43(1):25-31. PMID: 16758414.
      Citations: 334     Fields:    Translation:Humans
    250. Garey KW, Graham G, Gerard L, Dao T, Jiang ZD, Price M, Dupont HL. Prevalence of diarrhea at a university hospital and association with modifiable risk factors. Ann Pharmacother. 2006 Jun; 40(6):1030-4. PMID: 16684806.
      Citations: 9     Fields:    Translation:HumansCells
    251. Garey KW, Neuhauser MM, Bearden DT, Cannon JP, Lewis RE, Gentry LO, Kontoyiannis DP. Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study. Mycoses. 2006 May; 49(3):226-31. PMID: 16681815.
      Citations: 7     Fields:    Translation:Humans
    252. Jiang ZD, DuPont HL, Garey K, Price M, Graham G, Okhuysen P, Dao-Tran T, LaRocco M. A common polymorphism in the interleukin 8 gene promoter is associated with Clostridium difficile diarrhea. Am J Gastroenterol. 2006 May; 101(5):1112-6. PMID: 16573784.
      Citations: 29     Fields:    Translation:HumansCells
    253. Tam VH, Adams S, LaRocco MT, Gerard LN, Gentry LO, Garey KW. An integrated pharmacoeconomic approach to antimicrobial formulary decision-making. Am J Health Syst Pharm. 2006 Apr 15; 63(8):735-9. PMID: 16595813.
      Citations: 1     Fields:    Translation:HumansCells
    254. Kachroo S, Dao T, Zabaneh F, Reiter M, Larocco MT, Gentry LO, Garey KW. Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant enterococcus colonization. Ann Pharmacother. 2006 Mar; 40(3):381-5. PMID: 16478809.
      Citations: 9     Fields:    Translation:HumansCellsCTClinical Trials
    255. Suda KJ, Garey KW, Danziger LH. Treatment failures secondary to drug interactions with divalent cations and fluoroquinolone. Pharm World Sci. 2005 Apr; 27(2):81-2. PMID: 15999916.
      Citations: 3     Fields:    Translation:Humans
    256. Gerard L, Garey KW, DuPont HL. Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections. Expert Rev Anti Infect Ther. 2005 Apr; 3(2):201-11. PMID: 15918778.
      Citations: 28     Fields:    Translation:Humans
    257. Garey KW, Johle ML, Behrman K, Neuhauser MM. Economic consequences of unused medications in Houston, Texas. Ann Pharmacother. 2004 Jul-Aug; 38(7-8):1165-8. PMID: 15138296.
      Citations: 18     Fields:    Translation:HumansPHPublic Health
    258. Garey KW, Neuhauser MM, Robbins RA, Danziger LH, Rubinstein I. Markers of inflammation in exhaled breath condensate of young healthy smokers. Chest. 2004 Jan; 125(1):22-6. PMID: 14718416.
      Citations: 33     Fields:    Translation:HumansCells
    259. Gotfried MH, Jung R, Messick CR, Rubinstein I, Garey KW, Rodvold KA, Danziger LH. Effects of six-week clarithromycin therapy in corticosteroid-dependent asthma: A randomized, double-blind, placebo-controlled pilot study. Curr Ther Res Clin Exp. 2004 Jan; 65(1):1-12. PMID: 24936100; PMCID: PMC4052968.
      Citations: 6     Fields:    
    260. Neuhauser MM, Wiley D, Simpson L, Garey KW. Involvement of immunization-certified pharmacists with immunization activities. Ann Pharmacother. 2004 Feb; 38(2):226-31. PMID: 14742755.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    261. Cannon JP, Fiscella R, Pattharachayakul S, Garey KW, De Alba F, Piscitelli S, Edward DP, Danziger LH. Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model. Invest Ophthalmol Vis Sci. 2003 May; 44(5):2112-7. PMID: 12714650.
      Citations: 20     Fields:    Translation:AnimalsCells
    262. Garey KW, Alwani A, Danziger LH, Rubinstein I. Tissue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseases. Chest. 2003 Jan; 123(1):261-5. PMID: 12527628.
      Citations: 10     Fields:    Translation:HumansCells
    263. Pendland SL, Neuhauser MM, Garey KW, Prause JL, Jung R. Comparative killing rates of gatifloxacin and ciprofloxacin against 14 clinical isolates: impact of bacterial strain and antibiotic concentration. Diagn Microbiol Infect Dis. 2002 Sep; 44(1):59-61. PMID: 12376032.
      Citations: 2     Fields:    Translation:HumansCells
    264. Tornatore KM, Garey KW, Saigal N, Reed K, Murray B, Ingalls E, DiFrancesco R, Forrest A, Morse G, Venuto R. Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection. Clin Transplant. 2001 Oct; 15(5):297-308. PMID: 11678955.
      Citations: 4     Fields:    Translation:Humans
    265. Bearden DT, Neuhauser MM, Garey KW. Telithromycin: an oral ketolide for respiratory infections. Pharmacotherapy. 2001 Oct; 21(10):1204-22. PMID: 11601667.
      Citations: 3     Fields:    Translation:HumansCells
    266. Cannon JP, Garey KW, Danziger LH. A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid-based amphotericin B formulations. Pharmacotherapy. 2001 Sep; 21(9):1107-14. PMID: 11560200.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    267. Mutlu GM, Garey KW, Robbins RA, Danziger LH, Rubinstein I. Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med. 2001 Sep 01; 164(5):731-7. PMID: 11549524.
      Citations: 63     Fields:    Translation:Humans
    268. Garey KW, Pendland SL, Huynh VT, Bunch TH, Jensen GM, Pursell KJ. Cunninghamella bertholletiae infection in a bone marrow transplant patient: amphotericin lung penetration, MIC determinations, and review of the literature. Pharmacotherapy. 2001 Jul; 21(7):855-60. PMID: 11444582.
      Citations: 10     Fields:    Translation:HumansAnimals
    269. Garey KW, Tesoro E, Muggia V, Pasquier O, Rodvold KA. Cerebrospinal fluid concentrations of quinupristin-dalfopristin in a patient with vancomycin-resistant Enterococcus faecium [correction of faecalis] ventriculitis. Pharmacotherapy. 2001 Jun; 21(6):748-50. PMID: 11401187.
      Citations: 2     Fields:    Translation:HumansCells
    270. Garey KW, Teichner P. Pharmacist intervention program for hospitalized patients with HIV infection. Am J Health Syst Pharm. 2000 Dec 15; 57(24):2283-4. PMID: 11146973.
      Citations: 5     Fields:    Translation:Humans
    271. Garey KW, Rubinstein I, Gotfried MH, Khan IJ, Varma S, Danziger LH. Long-term clarithromycin decreases prednisone requirements in elderly patients with prednisone-dependent asthma. Chest. 2000 Dec; 118(6):1826-7. PMID: 11115481.
      Citations: 11     Fields:    Translation:Humans
    272. Pendland SL, Diaz-Linares M, Garey KW, Woodward JG, Ryu S, Danziger LH. Bactericidal activity and postantibiotic effect of levofloxacin against anaerobes. Antimicrob Agents Chemother. 1999 Oct; 43(10):2547-9. PMID: 10508042; PMCID: PMC89518.
      Citations: 3     Fields:    Translation:HumansCells
    273. Garey KW, Peloquin CA, Godo PG, Nafziger AN, Amsden GW. Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers. Antimicrob Agents Chemother. 1999 May; 43(5):1152-5. PMID: 10223928; PMCID: PMC89125.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    274. Garey KW, Amsden GW. Intravenous azithromycin. Ann Pharmacother. 1999 Feb; 33(2):218-28. PMID: 10084418.
      Citations: 10     Fields:    Translation:Humans
    275. Garey KW, Amsden GW. Trovafloxacin: an overview. Pharmacotherapy. 1999 Jan; 19(1):21-34. PMID: 9917076.
      Citations: 6     Fields:    Translation:Humans
    276. Garey KW, Streetman DS, Rainish MC. Azathioprine hypersensitivity reaction in a patient with ulcerative colitis. Ann Pharmacother. 1998 Apr; 32(4):425-8. PMID: 9562137.
      Citations: 4     Fields:    Translation:Humans
    277. Garey KW, Amsden GW, Johns CA. Possible interaction between imipramine and butalbital. Pharmacotherapy. 1997 Sep-Oct; 17(5):1041-2. PMID: 9324197.
      Citations: 1     Fields:    Translation:Humans
    GAREY's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (668)
    Explore
    _
    Co-Authors (47)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _